SMMT
Summit Therapeutics PLC
17.70$
+2.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Summit Therapeutics PLC (SMMT) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/15/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/14/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/26/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/05/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/23/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 07/23/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 07/23/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 07/22/2026 | Current report (8-K) | Summit Therapeutics Inc. (SMMT): Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.